Literature DB >> 2708613

Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia.

J A Said, B G Waters, P Cousens, M M Stevens.   

Abstract

We assessed neuropsychologically 106 children with acute lymphoblastic leukemia (ALL) who had all received cranial irradiation for the prevention of central nervous system (CNS) leukemia 1-13 years previously. Children were assessed for adverse late effects of their therapy, using age-appropriate Wechsler measures of overall intellectual ability and supplementary tests. Forty-five siblings near in age to the patients were tested as controls. The patients who had had the most intensive central nervous system (CNS) prophylaxis were found to have a WISC-R Full Scale IQ 17 points lower than the sibling control group. Performance IQ was more affected than verbal IQ. The patients were more easily distracted and less able to concentrate. The severity of the aftereffects was related to younger age at the time of CNS prophylaxis and to a higher dose of cranial irradiation but not to time since CNS prophylaxis. CNS prophylaxis using a combination of cranial irradiation and intrathecal methotrexate has lowered the incidence of CNS relapse in childhood ALL but is associated with considerable long-term morbidity in survivors.

Entities:  

Mesh:

Year:  1989        PMID: 2708613     DOI: 10.1037//0022-006x.57.2.251

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  10 in total

Review 1.  Cognitive deficits in children treated for leukaemia.

Authors:  C Eiser
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

2.  Memory after treatment for acute lymphoblastic leukaemia.

Authors:  J Rodgers; P G Britton; R G Morris; J Kernahan; A W Craft
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

3.  Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Authors:  Oussama Abla; Sheila Weitzman; Jean-Yves Blay; Brian Patrick O'Neill; Lauren E Abrey; Edward Neuwelt; Nancy D Doolittle; Joachim Baehring; Kamnesh Pradhan; S Eric Martin; Michael Guerrera; Shafqat Shah; Hervé Ghesquieres; Michael Silver; Rebecca A Betensky; Tracy Batchelor
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

4.  Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.

Authors:  Jong Hyung Yoon; Hyoung Jin Kang; Hyery Kim; Ji Won Lee; June Dong Park; Kyung Duk Park; Hee Young Shin; Hyo Seop Ahn
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

5.  Attentional ability among survivors of leukaemia.

Authors:  J Rodgers; J Horrocks; P G Britton; J Kernahan
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 6.  Management of primary central nervous system lymphoma in children.

Authors:  Lisa Giulino-Roth; Oussama Abla; Tracy T Batchelor
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

7.  Attentional ability among survivors of leukaemia treated without cranial irradiation.

Authors:  J Rodgers; R Marckus; P Kearns; K Windebank
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

8.  Health-related quality of life and cognitive outcomes among child and adolescent survivors of leukemia.

Authors:  Shyh-Shin Chiou; Ren-Chin Jang; Yu-Mei Liao; Pinchen Yang
Journal:  Support Care Cancer       Date:  2009-12-01       Impact factor: 3.603

9.  Differential diagnosis of a vanishing brain space occupying lesion in a child.

Authors:  Sherifa A Hamed; Mohamad A Mekkawy; Hosam Abozaid
Journal:  World J Clin Cases       Date:  2015-11-16       Impact factor: 1.337

10.  Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta-analysis.

Authors:  Kalliopi Mavrea; Vasiliki Efthymiou; Katerina Katsibardi; Konstantinos Tsarouhas; Christina Kanaka-Gantenbein; Demetrios A Spandidos; George Chrousos; Antonis Kattamis; Flora Bacopoulou
Journal:  Oncol Lett       Date:  2021-02-05       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.